1998
DOI: 10.1097/00004647-199805000-00010
|View full text |Cite
|
Sign up to set email alerts
|

Long-Term Neuroprotection by Benzodiazepine: Full Versus Partial Agonists after Transient Cerebral Ischemia in the Gerbil

Abstract: The ability of diazepam, a benzodiazepine full agonist, and imidazenil, a benzodiazepine partial agonist, to protect hippocampal area CA1 neurons from death for at least 35 days after cerebral ischemia was investigated. Diazepam (10 mg/kg) administered to gerbils 30 and 90 minutes after forebrain ischemia produced significant protection of hippocampal area CA1 pyramidal neurons 7 days later. In gerbils surviving for 35 days, diazepam produced the same degree of neuroprotection (70% +/- 30%) in the hippocampus … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
28
0

Year Published

2001
2001
2015
2015

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 47 publications
(28 citation statements)
references
References 49 publications
0
28
0
Order By: Relevance
“…Such a bimodal distribution of ischemic CA1 damage has also been reported after treatment with different compounds, such as the AMPA receptor antagonist, NBQX (27,28), the benzodiazepine agonist, diazepam (24,29,30), and the partial benzodiazepine agonist, imidazenil (24). Such variability in response is thought to result from a combination of at least two factors, i.e., normal variation of damage in the model, and differences in the real concentration of the drug which reaches the brain in each individual (27).…”
Section: Discussionmentioning
confidence: 56%
See 1 more Smart Citation
“…Such a bimodal distribution of ischemic CA1 damage has also been reported after treatment with different compounds, such as the AMPA receptor antagonist, NBQX (27,28), the benzodiazepine agonist, diazepam (24,29,30), and the partial benzodiazepine agonist, imidazenil (24). Such variability in response is thought to result from a combination of at least two factors, i.e., normal variation of damage in the model, and differences in the real concentration of the drug which reaches the brain in each individual (27).…”
Section: Discussionmentioning
confidence: 56%
“…In the present study, the neuroprotective effect of FK506 was sustained at least up to 30 days after the beginning of treatment; however, neuroprotection was less than, but not statistically different from, that measured 7 days after ischemia. Sustained neuroprotection for approximately 30 days of recovery has also been obtained with benzodiazepine-related compounds (24) and felbamate (25) in the gerbil, and after mild hypothermia in the rat (26). In contrast, the neuroprotective effect of the GABA reuptake inhibitor tiagabine is evident at 4 days, but not after 21 days of recovery (14).…”
Section: Discussionmentioning
confidence: 92%
“…80,81 As demonstrated in laboratory animal studies of focal and global ischemia, antiepileptic drugs may also act as neuroprotectants. 82 For example, phenytoin, 83 benzodiazepines, 84 lamotrigine, [85][86][87][88] topiramate, 89 -91 levetiracetam, 92 and zonisamide 93 have neuroprotective properties and might, therefore, have beneficial effects when used to treat seizures in the setting of hyperacute stroke. However, there remain no clinical data proving this to be true, and the comparative risks and benefits of the different antiepileptic drugs have not been well studied in stroke patients.…”
Section: Treatmentmentioning
confidence: 99%
“…[In vivo, if diazepam administration is delayed Ͼ2 hr after ischemia, its neuroprotective ability is lost (Schwartz-Bloom et al, 1998)]. At this time, diazepam could still promote neuronal inhibition even as intracellular Cl Ϫ starts to rise.…”
Section: Ogd and The Effect Of Diazepammentioning
confidence: 99%